Partnership aims to reduce barriers to care for hypertension and diabetes patients Northampton, MA --News Direct-- Medtronic Dorcas Mwende Mulei with Medtronic LABS patient engagement lead and community health worker Dorcas Mwende Mulei was at the height of her career working as a businesswoman in Kenya’s rural Makueni County when complications from diabetes confined the 46-year-old to her home. Now she’s on the mend, thanks to her involvement in Medtronic LABS’ patient support groups at a clinic just a short walk from her home. The support groups are part of LABS’ Empower Health program in Kenya, which is now expanding from six counties to the entire country of nearly 54 million people. The expansion was announced at a roundtable event with healthcare leaders from across Kenya, including key partners, such as Kenya’s Ministry of Health, World Diabetes Foundation, Kenya Defeat Diabetes Association, PATH, and others. Hypertension and diabetes are a major health concern in Kenya, affecting millions. The Empower Health expansion will roll out over the next three years and has the potential to impact over 300,000 people living with these chronic diseases. “Scaling this program in Kenya is just the beginning of strengthening the health system and eventually reaching 100% of affected people through multistakeholder partnerships,” said Eric Angula, Head of Partnerships and Government Affairs in Africa for Medtronic LABS. A comprehensive model of care An independent nonprofit organization funded by Medtronic, Medtronic LABS is dedicated to creating technology-powered healthcare solutions to accelerate patient access for underserved communities around the world by combining digital technology, field operations, and partnerships. Born out of former Medtronic CEO and Chairman Omar Ishrak’s desire to expand access to quality healthcare for people living in emerging markets, the organization has continued to grow in alignment with this original vision. “The core of the Medtronic Mission to use technology to alleviate pain, restore health, and extend life applies to everybody in the world,” Ishrak, who serves on LABS’ board, said. “Technology has enabled a whole new layer of healthcare in underserved communities.” The technology platform is part of what makes LABS so effective. The organization has also been strategic about plugging into existing healthcare infrastructure, forging strong partnerships along the way. The landmark public-private partnership with the Ministry of Health of Kenya, the County Government of Makueni, World Diabetes Foundation, Kenya Defeat Diabetes Association, and others has allowed LABS to reach over 42,000 patients in Kenya. In Makueni County, where Mulei lives, the program has reached over 14,000 patients. "This is one of the most important public-private partnerships that we've done since our inception as a government," said His Excellency the Governor of Makueni County Professor Kivutha Kibwana. The Empower Health program started in 2018 with one hospital. It’s grown into a comprehensive model, offering patient screening, diagnosis, disease management, education, tele-counseling, and peer support groups. Medtronic LABS has trained over 300 Community Health Volunteers to screen patients for hypertension and diabetes in Kenya. Equipped with a tablet or cell phone with LABS’ tech, a weighing scale, blood pressure monitor, and blood glucometer, they are assigned patients in their community. Once screened, the patients are connected with healthcare in a clinic or hospital. Then, the Community Health Volunteer visits their home twice a month. Combined with monthly patient support groups, this approach has led to better outcomes and an increased number of patients in Makueni County maintaining their care plans. ‘Multiply the impact’ For patients like Mulei, who live in hard-to-reach areas, the impact can’t be overstated. She earned the majority of the family’s income until her diabetes complications caused a wound on her foot bad enough to keep her home from work. Now that she has the care and support she needs, she’ll be able to start working ―and caring for her family ―again. “I have good hopes that through the support group I won’t be bothered by the diabetes and my wound and live happily,” she said. For Mulei and the other 6 million Kenyans living with hypertension and diabetes, Empower Health offers hope and new beginnings. “Empower Health is a model for how we can expand these programs, not just in Kenya, but in sub-Saharan Africa and eventually other parts of the world,” said Ruchika Singhal, President of Medtronic LABS. “You start to multiply the impact with people living in low-and-middle-income countries, and we’re talking about hundreds of millions of people that could potentially be impacted.” Learn more about Medtronic LABS here. View additional multimedia and more ESG storytelling from Medtronic on 3blmedia.com View source version on newsdirect.com: https://newsdirect.com/news/medtronic-labs-and-partners-expand-healthcare-access-in-kenya-267970398
Medtronic LABS and Partners Expand Healthcare Access in Kenya
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...